Yesterday, we attended the "Breakthroughs in Precision Oncology" event at JLABS NYC. Insightful discussions on advancing personalized cancer treatment with experts from Cancer Research Institute, Albert Einstein College of Medicine - Official, Mount Sinai Health System, and Memorial Sloan Kettering Cancer Center. Thanks to JLABS for hosting! #biotech

Thanks Scorpius Bio & DCAT for inviting us to the 96th DCAT Annual Dinner. Inspiring words from guest speaker Tom Brady on excellence & philanthropy. #biotech #innovation #NYC #investing

Grateful to post-dinner event hosts Amcor , Asymchem, Lonza, Resilience , The Siegfried Group, @TakasagoGlobal, Thermo Fisher, & WuXi AppTec for fostering industry connections

🎉 Exciting collaboration with Javed Khan & TumeyLab on novel FGFR4-targeted ADC for rhabdomyosarcoma & other cancers, presented at #AACR2024 ! Thanks to lead investigators and their lab members. prlog.org/13015427-manha… abstractsonline.com/pp8/#!/20272/p… #biotech #cancer #ADC

Exciting milestone! A U.S. patent application has been filed for our novel ADC cancer therapy, developed in collaboration with National Cancer Institute and Binghamton University. New hope to patients battling difficult-to-treat cancers. #biotech tinyurl.com/5n875vck

Developing the next generation of antibody drug conjugates: Léo Marx of Debiopharm details how the therapeutic window of ADCs can be impacted, how we can overcome the challenges associated with achieving site-specific conjugation drugtargetreview.com/article/148277… #ADC #Innovation #Cancer

Our team had an incredible time at the 2024 JLABS Investor & Partnering Day! We connected with innovative biotechs, investors, and Johnson & Johnson Innovation leaders. Excited to drive our projects forward ! linkedin.com/company/manhat…

Manhattan BioSolutions team had an incredible evening at the exclusive event hosted by SternAegis Ventures & Aegis Capital Corp at the stunning RT60 Rooftop Bar & Lounge in NYC. Great conversations, new connections, and breathtaking views! #Biotech #Innovation

Impressive turnout at the #EFHuttonConference2024 yesterday at the iconic Plaza Hotel in NYC. Great opportunity for execs & investors to connect. Insightful discussions on #SPACs, #IPOs & more. Perfect ending at the post-conference social linkedin.com/posts/manhatta…

Manhattan BioSolutions was honored to be selected to present at the Mansfield Bioinc event last week, showcasing our groundbreaking approach to cancer treatment using precision biologics. linkedin.com/posts/manhatta…

How antibody–drug conjugates aim to take down cancer nature.com/articles/d4158… linkedin.com/company/manhat… #ADCs #biotech #cancer

Manhattan BioSolutions Partners to Advance Taxoids as Innovative ADC Payloads prlog.org/13026533-manha… #biotech #ADC #cancer #innovation

Congrats to our advisor Dr. Tumey on groundbreaking ADC paper in Xenobiotica! Legumain-cleavable linkers: match/exceed ValCit ADCs; broad tumor activity; better stability. Manhattan BioSolutions leveraging this tech for next-gen LEG-TOP1i ADC therapies! TumeyLab #ADCs #Cancer

Excited to be featured in Binghamton University's latest story on our collaboration with TumeyLab and Javed Khan #oncology #ADC binghamton.edu/news/story/514…

Proud to participate in the exclusive JLABS Global CEO Summit 2024 at NYSE 🏛 ! Inspiring keynote from Bob Langer, valuable IPO insights, and great connections. Thank you JLABS Johnson & Johnson Innovation for including us - excited to keep advancing next-gen targeted therapies! #innovation

Last week at #PrixGalien Alexandria Center Amazing panels with Nobel Laureate Phil Sharp, Noubar Afeyan Moderna , George Yancopoulos Regeneron & Mikael Dolsten Pfizer Inc. sharing visions for biotech future. Congrats to all The Galien Foundation award winners! #innovation #biotech

Manhattan BioSolutions Initiates NCI PIVOT Collaboration in Pediatric Cancers prlog.org/13059499-manha… linkedin.com/posts/manhatta… #cancer #biotech #Innovation

Manhattan BioSolutions Secures Expanded Rights to Novel Legumain-Cleavable Topoisomerase 1 Inhibitor (TOP1i) ADC Platform After Successful Multi-Target Validation linkedin.com/posts/manhatta… #biotech #ADCs #cancer #Innovation TumeyLab Javed Khan Dr. Dhaval K. Shah

Breakthrough at #AACR2025: Our LEG-cleavable ADCs show complete tumor elimination in RMS models. Exciting validation of our technology against rare pediatric cancers. Thanks to our collaborators at NCI/NIH and Binghamton University! TumeyLab Javed Khan AACR

Manhattan Bio' Collaborative TxD ADC Project Receives REACH Award from Center for Biotech. Partnership advances novel taxoid-based payload technology for cancer-resistant tumors. linkedin.com/posts/manhatta… #ADC #Biotech #Innovation Dr. Dhaval K. Shah